Similar to our findings, studies have shown that Mortalin can regulate mitochondrial membrane permeability and membrane potential by inhibiting the interaction between SLC25A6 and CypD, which suppresses mPTP opening, ultimately promoting the survival of BRAF-mutant tumor cells [46]. The gene discussed is HSPA9; the disease is neoplasm.